- Home
- EIC vs SOPH Comparison
EIC vs SOPH Comparison
Compare EIC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.8M | 330.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EIC | SOPH |
|---|---|---|
| Price | $11.48 | $4.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $7.00 |
| AVG Volume (30 Days) | ★ 287.7K | 99.0K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | ★ 13.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | $59,262,402.00 | ★ $73,297,000.00 |
| Revenue This Year | $37.84 | $18.32 |
| Revenue Next Year | $23.33 | $15.61 |
| P/E Ratio | $10.00 | ★ N/A |
| Revenue Growth | ★ 44.30 | 13.66 |
| 52 Week Low | $10.81 | $2.58 |
| 52 Week High | $16.39 | $5.30 |
Technical Indicators
Market Signals| Indicator | EIC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 52.57 | 53.24 |
| Support Level | $11.00 | $4.60 |
| Resistance Level | $11.44 | $4.95 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 93.24 | 32.89 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.